Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,721 followers.

RT @FrontOncology: New research: Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung…

20 Mar 2024

Reply Repost Favourite

New research: Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations: Background For patients with EGFR/HER2 exon20 insertions,… https://t.co/MjcWmtjDex

20 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.